{
  "main_header": {
    "sid": 930938,
    "name": "Gennex Lab.",
    "stock_name": "Gennex Lab.",
    "full_name": "Gennex Laboratories Ltd",
    "name_url": "stocks-analysis/gennex-lab",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "9.67",
    "chg": -0.1,
    "chgp": "-1.02%",
    "dir": -1,
    "prev_price": "9.77",
    "mcapval": "240.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 531739,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE509C01026",
    "curr_date": "Oct 09",
    "curr_time": "",
    "bse_nse_vol": "2.83 lacs",
    "exc_status": "Active",
    "traded_date": "Oct 09, 2026",
    "traded_date_str": "2026 10 09",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://marketsmojo.motilaloswal.com/MOSL-Landingstocks-analysis/gennex-lab-930938-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [],
    "total": 15,
    "sid": "930938",
    "stock_news_url": "https://marketsmojo.motilaloswal.com/news/gennex-laboratories-930938"
  },
  "announcements": [
    {
      "caption": "Shareholder Meeting / Postal Ballot-Scrutinizers Report",
      "datetime": "01-Oct-2026",
      "details": "In compliance to Regulation 44 of SEBI (LODR) Regulations 2015 as amended from time to time please find enclosed herewith voting results of the 41st eAGM of the Company held on September 30 2026 at 12.30 Hrs through VC/OAVM along with the consolidated Scrutinizers report.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
      "datetime": "30-Sep-2026",
      "details": "Pursuant to Regulation 30 read with Part A of Schedule III of SEBI (LODR) Regulations 2015 we would like to inform you that the Company has received approval of its members by Special Resolution passed in the 41st AGM of the Company held on September 30 2026 for appointment of Mr. Dipankar Dasgupta as Independent Non-Executive Director of the Company with effect from October 01 2026 in place of retiring Independent Non Executive Director Mr. Amudala Sreeramulu Nageswar Rao whose current period of office has expired on the date of AGM i.e. September 30 2026.",
      "source": "BSE"
    },
    {
      "caption": "Shareholder Meeting / Postal Ballot-Outcome of AGM",
      "datetime": "30-Sep-2026",
      "details": "Pursuant to Regulation 30 of SEBI (LODR) Regulations 2015 we are pleased to provide hereunder the proceedings of 41st eAGM of the Company held on Wednesday September 30 2026 through VC and OAVM. The meeting was held in compliance to the General Circular no. 03/2025 dated September 22 2025 issued by MCA and Circular no. 2024/133 dated October 03 2024 issued by SEBI Companies are allowed to hold AGM through VC and OAVM without the physical presence of members at a common venue till further notice and other applicable provisions of the Companies Act 2013 read with rules made thereunder.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Gennex Laboratories Ltd has announced <strong>1:10</strong> stock split, ex-date: 14 Dec 09",
          "dt": "2009-12-14",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "",
      "data": [
        {
          "txt": "Gennex Laboratories Ltd has announced <strong>1:2</strong> rights issue, ex-date: 21 Jul 22",
          "dt": "2022-07-21",
          "middle_text": "Rights Issue"
        }
      ]
    }
  ]
}

News and Views

No Recent News for the Company

View All News